Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 552

1.

Isoform-specific NF1 mRNA levels correlate with disease severity in Neurofibromatosis type 1.

Assunto A, Ferrara U, De Luca A, Pivonello C, Lombardo L, Piscitelli A, Tortora C, Pinna V, Daniele P, Pivonello R, Russo MG, Limongelli G, Colao A, Tartaglia M, Strisciuglio P, Melis D.

Orphanet J Rare Dis. 2019 Nov 15;14(1):261. doi: 10.1186/s13023-019-1223-1.

2.

Cost-consequence analysis for human recombinant growth hormone (r-hGH) treatment administered via different devices in children with growth hormone deficiency in Italy.

Foo J, Maghnie M, Colao A, Vlachaki I, Colombo G.

Clinicoecon Outcomes Res. 2019 Aug 22;11:525-537. doi: 10.2147/CEOR.S195265. eCollection 2019.

3.

The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide.

Muscogiuri G, Barrea L, Laudisio D, Pugliese G, Salzano C, Savastano S, Colao A.

J Transl Med. 2019 Oct 29;17(1):356. doi: 10.1186/s12967-019-2104-z. Review.

4.

Author Correction: Acromegaly.

Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM, Pivonello R.

Nat Rev Dis Primers. 2019 Oct 21;5(1):72. doi: 10.1038/s41572-019-0129-5.

PMID:
31636262
5.

A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update.

Giustina A, Barkan A, Beckers A, Biermasz N, Biller BMK, Boguszewski C, Bolanowski M, Bonert V, Bronstein MD, Casanueva FF, Clemmons D, Colao A, Ferone D, Fleseriu M, Frara S, Gadelha MR, Ghigo E, Gurnell M, Heaney AP, Ho K, Ioachimescu A, Katznelson L, Kelestimur F, Kopchick J, Krsek M, Lamberts S, Losa M, Luger A, Maffei P, Marazuela M, Mazziotti G, Mercado M, Mortini P, Neggers S, Pereira AM, Petersenn S, Puig-Domingo M, Salvatori R, Shimon I, Strasburger C, Tsagarakis S, van der Lely AJ, Wass J, Zatelli MC, Melmed S.

J Clin Endocrinol Metab. 2019 Oct 13. pii: dgz096. doi: 10.1210/clinem/dgz096. [Epub ahead of print]

PMID:
31606735
6.

Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors <2 cm.

Faggiano A, Modica R, Lo Calzo F, Camera L, Napolitano V, Altieri B, de Cicco F, Bottiglieri F, Sesti F, Badalamenti G, Isidori AM, Colao A.

J Clin Endocrinol Metab. 2019 Oct 5. pii: dgz007. doi: 10.1210/clinem/dgz007. [Epub ahead of print]

PMID:
31586182
7.

Breast cancer prevention in premenopausal women: role of the Mediterranean diet and its components.

Laudisio D, Barrea L, Muscogiuri G, Annunziata G, Colao A, Savastano S.

Nutr Res Rev. 2019 Oct 1:1-14. doi: 10.1017/S0954422419000167. [Epub ahead of print]

PMID:
31571551
8.

Italian university rectors for health and environment: the U4ALL initiative.

Miani A, Piscitelli P, Uricchio AF, Franzini E, Frati F, Lauro R, Zara V, Profita G, Deiana A, Colao A, Manfredi G.

Lancet. 2019 Oct 12;394(10206):1319. doi: 10.1016/S0140-6736(19)31340-6. Epub 2019 Sep 26. No abstract available.

PMID:
31564524
9.

Pituitary magnetic resonance imaging predictive role in the therapeutic response of growth hormone-secreting pituitary adenomas.

Tortora F, Negro A, Grasso LFS, Colao A, Pivonello R, Splendiani A, Brunese L, Caranci F.

Gland Surg. 2019 Sep;8(Suppl 3):S150-S158. doi: 10.21037/gs.2019.06.04.

10.

Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS).

Barrea L, Arnone A, Annunziata G, Muscogiuri G, Laudisio D, Salzano C, Pugliese G, Colao A, Savastano S.

Nutrients. 2019 Sep 23;11(10). pii: E2278. doi: 10.3390/nu11102278.

11.

Non-conventional doses of somatostatin analogs in patients with progressing well differentiated neuroendocrine tumor.

Lamberti G, Faggiano A, Brighi N, Tafuto S, Ibrahim T, Brizzi MP, Pusceddu S, Albertelli M, Massironi S, Panzuto F, Badalamenti G, Riccardi F, Butturini G, Gelsomino F, De Divitiis C, Modica R, Bongiovanni A, La Salvia A, Torchio M, Colao A, Ferone D, Campana D; ItaNet.

J Clin Endocrinol Metab. 2019 Sep 23. pii: dgz035. doi: 10.1210/clinem/dgz035. [Epub ahead of print]

PMID:
31545377
12.

Somatotropic Axis and Obesity: Is There Any Role for the Mediterranean Diet?

Muscogiuri G, Barrea L, Laudisio D, Di Somma C, Pugliese G, Salzano C, Colao A, Savastano S.

Nutrients. 2019 Sep 16;11(9). pii: E2228. doi: 10.3390/nu11092228.

13.

Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management.

Altieri B, Di Dato C, Martini C, Sciammarella C, Di Sarno A, Colao A, Faggiano A; NIKE Group.

Cancers (Basel). 2019 Sep 8;11(9). pii: E1332. doi: 10.3390/cancers11091332. Review.

14.

Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms.

Tafuto S, von Arx C, Capozzi M, Tatangelo F, Mura M, Modica R, Barretta ML, Di Sarno A, Tornesello ML, Colao A, Ottaiano A.

J Clin Med. 2019 Aug 15;8(8). pii: E1224. doi: 10.3390/jcm8081224.

15.

Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit.

Provvisiero DP, Negri M, de Angelis C, Di Gennaro G, Patalano R, Simeoli C, Papa F, Ferrigno R, Auriemma RS, De Martino MC, Colao A, Pivonello R, Pivonello C.

Sci Rep. 2019 Aug 12;9(1):11695. doi: 10.1038/s41598-019-48081-9.

16.

Metabolic Disorders and Male Hypogonadotropic Hypogonadism.

Pivonello R, Menafra D, Riccio E, Garifalos F, Mazzella M, de Angelis C, Colao A.

Front Endocrinol (Lausanne). 2019 Jul 25;10:345. doi: 10.3389/fendo.2019.00345. eCollection 2019. Review.

17.

The role of mTOR pathway as target for treatment in adrenocortical cancer.

De Martino MC, Feelders RA, Pivonello C, Simeoli C, Papa FC, Colao AA, Pivonello R, Hofland LJ.

Endocr Connect. 2019 Aug 1. pii: EC-19-0224.R1. doi: 10.1530/EC-19-0224. [Epub ahead of print] Review.

18.

Female infertility: which role for obesity?

Gambineri A, Laudisio D, Marocco C, Radellini S, Colao A, Savastano S; Obesity Programs of nutrition, Education, Research and Assessment (OPERA) group.

Int J Obes Suppl. 2019 Apr;9(1):65-72. doi: 10.1038/s41367-019-0009-1. Epub 2019 Apr 12. Review.

19.

How much does obesity affect the male reproductive function?

Bellastella G, Menafra D, Puliani G, Colao A, Savastano S; Obesity Programs of nutrition, Education, Research and Assessment (OPERA) Group.

Int J Obes Suppl. 2019 Apr;9(1):50-64. doi: 10.1038/s41367-019-0008-2. Epub 2019 Apr 12. Review.

20.

Nutritionist and obesity: brief overview on efficacy, safety, and drug interactions of the main weight-loss dietary supplements.

Barrea L, Altieri B, Polese B, De Conno B, Muscogiuri G, Colao A, Savastano S; Obesity Programs of Nutrition, Education, Research and Assessment (OPERA) Group.

Int J Obes Suppl. 2019 Apr;9(1):32-49. doi: 10.1038/s41367-019-0007-3. Epub 2019 Apr 12. Review.

Supplemental Content

Loading ...
Support Center